NEW YORK (TheStreet) -- Shares of Agilent Technologies (A) - Get Report are up 0.11% to $44.46 early Wednesday afternoon as Leerink raised its price target to $51 from $44 and maintained its "outperform" rating.

"Our 'outperform' rating on Agilent reflects a view that the company has the most top-line independent margin expansion opportunity in large-cap life science tools," Leerink analysts said in an investor note, referencing "solid" 2016 second quarter results.

On Monday, Agilent reported earnings rose 6% year-over-year to 44 cents per share on revenue of $1.02 billion for its second quarter. Analysts expected earnings of 39 cents per share on revenue of $983.3 million.

Santa Clara, CA-based Agilent is a provider of application focused lab solutions that include instruments, software, services and consumables.

Separately, TheStreet Ratings rated Agilent Technologies as a "buy" with a score of B.

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon.

Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:

This is driven by some important positives, which TheStreet Ratings believes should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks that are covered.

The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins.

Although the company may harbor some minor weaknesses, TheStreet Ratings feels they are unlikely to have a significant impact on results.

You can view the full analysis from the report here: A

Image placeholder title